A prospective double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol
- 30 April 1994
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 124 (4) , 520-528
- https://doi.org/10.1016/s0022-3476(05)83128-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failureThe Lancet, 1991
- Measurement of renal function in chronic renal diseaseKidney International, 1990
- Laboratory quality control for a multicenter clinical trial: A report from the Growth Failure in Children with Renal Diseases StudyThe Journal of Pediatrics, 1990
- Data coordination and management in the Growth failure in Children with Renal Diseases StudyThe Journal of Pediatrics, 1990
- Growth failure in children with renal diseases study: An overview from the National Institutes of Health and the Advisory CommitteeThe Journal of Pediatrics, 1990
- 1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trialKidney International, 1989
- 25-Hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: Beneficial effect on linear growth velocityThe Journal of Pediatrics, 1982
- Is calcitriol [1,25(OH)2D3] harmful to renal function?Published by American Medical Association (AMA) ,1979
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978
- Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal OsteodystrophyNew England Journal of Medicine, 1978